- Home
- AKRO vs MTX Comparison
AKRO vs MTX Comparison
Compare AKRO & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- MTX
- Stock Information
- Founded
- AKRO 2017
- MTX 1968
- Country
- AKRO United States
- MTX United States
- Employees
- AKRO N/A
- MTX N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- MTX Major Chemicals
- Sector
- AKRO Health Care
- MTX Industrials
- Exchange
- AKRO Nasdaq
- MTX Nasdaq
- Market Cap
- AKRO 2.4B
- MTX 2.4B
- IPO Year
- AKRO 2019
- MTX 1992
- Fundamental
- Price
- AKRO $28.09
- MTX $80.68
- Analyst Decision
- AKRO Strong Buy
- MTX Strong Buy
- Analyst Count
- AKRO 7
- MTX 1
- Target Price
- AKRO $43.20
- MTX $97.00
- AVG Volume (30 Days)
- AKRO 617.2K
- MTX 162.7K
- Earning Date
- AKRO 11-08-2024
- MTX 10-24-2024
- Dividend Yield
- AKRO N/A
- MTX 0.55%
- EPS Growth
- AKRO N/A
- MTX 138.40
- EPS
- AKRO N/A
- MTX 4.71
- Revenue
- AKRO N/A
- MTX $2,124,900,000.00
- Revenue This Year
- AKRO N/A
- MTX N/A
- Revenue Next Year
- AKRO N/A
- MTX $5.22
- P/E Ratio
- AKRO N/A
- MTX $17.13
- Revenue Growth
- AKRO N/A
- MTX N/A
- 52 Week Low
- AKRO $14.41
- MTX $60.78
- 52 Week High
- AKRO $37.00
- MTX $90.30
- Technical
- Relative Strength Index (RSI)
- AKRO 38.58
- MTX 55.87
- Support Level
- AKRO $31.12
- MTX $80.45
- Resistance Level
- AKRO $35.11
- MTX $84.07
- Average True Range (ATR)
- AKRO 1.99
- MTX 1.84
- MACD
- AKRO -0.53
- MTX 0.22
- Stochastic Oscillator
- AKRO 11.68
- MTX 59.29
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About MTX Minerals Technologies Inc.
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into three segments based on product type. The specialty minerals segment, sells calcium carbonate, limestone, and talc, which is used in the paper, building materials, paint, automotive, and pharmaceutical industries. The refractories segment sells products for steel furnaces. The performance materials segment sells bentonite used in steel alloy casting and household products including cat litter. The majority of revenue comes from the United States.